Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Franceschini

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Journal of the American Society of Nephrology : JASN|October 2, 2021
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus NephritisAndrea Angeletti, Maurizio Bruschi, Gabriella Moroni, et al.
Autoimmunity Reviews|February 2, 2017
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective studyElena Bartoloni, Miguel A Gonzalez-Gay, Carlo Scirè, et al.
Clinical and Experimental Rheumatology|May 8, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Rheumatology (Oxford, England)|December 29, 2020
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysisMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
Rheumatology (Oxford, England)|December 22, 2020
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective studyMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
Rheumatology (Oxford, England)|April 26, 2025
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre studyPaolo Delvino, Luca Quartuccio, Joanna C Robson, et al.
Therapeutic Advances in Musculoskeletal Disease|March 5, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohortLiala Moschetti, Silvia Rovaris, Francesco Bonomi, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Journal of Autoimmunity|July 16, 2022
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseasesClodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, et al.
Scientific Reports|October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosusAlessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Journal of the American Society of Nephrology : JASN|October 2, 2021
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus NephritisAndrea Angeletti, Maurizio Bruschi, Gabriella Moroni, et al.
Autoimmunity Reviews|February 2, 2017
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective studyElena Bartoloni, Miguel A Gonzalez-Gay, Carlo Scirè, et al.
Clinical and Experimental Rheumatology|May 8, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Rheumatology (Oxford, England)|December 29, 2020
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysisMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
Rheumatology (Oxford, England)|December 22, 2020
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective studyMaurizio Bruschi, Gabriella Moroni, Renato Alberto Sinico, et al.
Rheumatology (Oxford, England)|April 26, 2025
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre studyPaolo Delvino, Luca Quartuccio, Joanna C Robson, et al.
Therapeutic Advances in Musculoskeletal Disease|March 5, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohortLiala Moschetti, Silvia Rovaris, Francesco Bonomi, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Journal of Autoimmunity|July 16, 2022
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseasesClodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, et al.
Scientific Reports|October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosusAlessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Pageof 24